| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Vanesa Perez, Ruth Garrido-Chaves, Mariola Zapater-Fajarí, Matias M Pulopulos, Vanesa Hidalgo, Alicia Salvado. EEG markers and subjective memory complaints in young and older people. International journal of psychophysiology : official journal of the International Organization of Psychophysiology. 2022-09-23. PMID:36150529. |
the eeg measures included were power spectral delta (0.5-4 hz), theta (4-8 hz), alpha (8-12 hz), beta (13-30 hz), and eeg reactivity to eo. |
2022-09-23 |
2023-08-14 |
human |
| Rohini Dwivedi, Poonam Sharma, Friederike Eilts, Fuming Zhang, Robert J Linhardt, Ritesh Tandon, Vitor H Pomi. Anti-SARS-CoV-2 and anticoagulant properties of Pentacta pygmaea fucosylated chondroitin sulfate depend on high molecular weight structures. Glycobiology. 2022-09-22. PMID:36136750. |
anti-sars-cov-2 properties were measured by concentration-response inhibitory curves of hek-293 t-hace2 cells infected with a baculovirus pseudotyped sars-cov-2 delta variant spike (s)-protein and competitive spr assays using multiple s-proteins [wuhan, n501y (alpha), k417t/e484k/n501y (gamma), l542r (delta) and omicron (ba.2 subvariant)]. |
2022-09-22 |
2023-08-14 |
Not clear |
| Valentine Marie Ferré, Nathan Peiffer-Smadja, Laura Kramer, Romain Coppée, Aïcha Kante, Margaux Debarge, Christophe Choquet, Thibault Saint Joannis, Donia Bouzid, Jonathan Messika, Jennifer Le Grand, Michael Thy, Solen Kernéis, Diane Descamps, Benoit Visseaux, Jade Ghos. Dual Monoclonal Antibodies on Sars-Cov-2 Alpha and Delta Variants: Clinical and Virological Efficacy. Microbiology spectrum. 2022-09-20. PMID:36125289. |
dual monoclonal antibodies on sars-cov-2 alpha and delta variants: clinical and virological efficacy. |
2022-09-20 |
2023-08-14 |
Not clear |
| Sam Li-Sheng Chen, Grace Hsiao-Hsuan Jen, Chen-Yang Hsu, Amy Ming-Fang Yen, Chao-Chih Lai, Yen-Po Yeh, Tony Hsiu-Hsi Che. A new approach to modeling pre-symptomatic incidence and transmission time of imported COVID-19 cases evolving with SARS-CoV-2 variants. Stochastic environmental research and risk assessment : research journal. 2022-09-19. PMID:36120386. |
the mptt (in days) increased from 3.45 (first period) ~ 4.02 (second period) of d614g until 3.94-4.65 of voc alpha but dropped to 3.93-3.49 of delta and 2 days (only first period) of omicron. |
2022-09-19 |
2023-08-14 |
Not clear |
| Thomas House, Heather Riley, Lorenzo Pellis, Koen B Pouwels, Sebastian Bacon, Arturas Eidukas, Kaveh Jahanshahi, Rosalind M Eggo, A Sarah Walke. Inferring risks of coronavirus transmission from community household data. Statistical methods in medical research. vol 31. issue 9. 2022-09-16. PMID:36112916. |
this provides evidence for: (i) temporally varying rates of introduction of infection into households broadly following the trajectory of the overall epidemic and vaccination programme; (ii) susceptible-infectious transmission probabilities of within-household transmission in the 15-35% range; (iii) the emergence of the alpha and delta variants, with the former being around 50% more infectious than wildtype and 35% less infectious than delta within households; (iv) significantly (in the range of 25-300%) more risk of bringing infection into the household for workers in patient-facing roles pre-vaccine; (v) increased risk for secondary school-age children of bringing the infection into the household when schools are open; (vi) increased risk for primary school-age children of bringing the infection into the household when schools were open since the emergence of new variants. |
2022-09-16 |
2023-08-14 |
Not clear |
| Ting Yan, Ye Xu, Rongrong Zheng, Xiaohong Zeng, Zehui Chen, Su Lin, Zihan Xia, Yiqun Liao, Yongyou Zhang, Qingge L. Accessible and Adaptable Multiplexed Real-Time PCR Approaches to Identify SARS-CoV-2 Variants of Concern. Microbiology spectrum. 2022-09-15. PMID:36106882. |
the selected mutations in alpha and delta variants were detected using multicolor melting curve analysis (mmca). |
2022-09-15 |
2023-08-14 |
Not clear |
| Emma Goulard Coderc de Lacam, Marharyta Blazhynska, Haochuan Chen, James C Gumbart, Christophe Chipo. When the Dust Has Settled: Calculation of Binding Affinities from First Principles for SARS-CoV-2 Variants with Quantitative Accuracy. Journal of chemical theory and computation. 2022-09-15. PMID:36108303. |
our estimates of the binding affinities support the view that while the alpha and beta variants lean on an increased affinity toward the host cell, the delta and omicron ba.2 variants choose immune escape. |
2022-09-15 |
2023-08-14 |
human |
| Katherine E Zarn, Sierra A Jaramillo, Anthony R Zapata, Nathan E Stone, Ashley N Jones, Haley E Nunnally, Erik W Settles, Ken Ng, Paul S Keim, Steen Knudsen, Patricia M Nuijten, Aloys S L Tijsma, Christopher T Frenc. Stenoparib, an inhibitor of cellular poly (ADP-ribose) polymerases (PARPs), blocks in vitro replication of SARS-CoV-2 variants. PloS one. vol 17. issue 9. 2022-09-14. PMID:36103462. |
here we show that stenoparib effectively inhibits a sars-cov-2 wild type (bavpat1/2020) strain and four additional variant strains; alpha (b.1.1.7), beta (b.1.351), delta (b.1.617.2) and gamma (p.1) in vitro, with 50% effective concentration (ec50) estimates of 4.1 μm, 8.5 μm, 24.1 μm, 8.2 μm and 13.6 μm, respectively. |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
severity of covid-19 cases in the months of predominance of the alpha and delta variants. |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
we aimed to assess and compare the symptoms and severity of cases due to the alpha and delta variant dominance periods, taking into account the effect of covid-19 vaccination. |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
a prospective epidemiological study of sars-cov-2 in lleida was made to determine differences between alpha and delta variants periods. |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
alpha variant period compared to the delta showed an increased risk of icu admission (aor 2.0; 95% ci 1.2-2.3) and death (aor 2.6; 95% ci 1.8-3.9) and cases were associated with people aged > 85 years (aor 2.1; 95% ci 1.7-2.6) and partially vaccinated (aor 5.6; 95% ci 3.2-9.9) and unvaccinated people (aor 27.8; 95% ci 19.7-40.5). |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
fever, cough and vomiting were significantly associated with the alpha variant compared to the delta (aor 1.6 (95% ci 1.5-1.7), 2.0 (95% ci 1.9-2.2) and 2.5 (95% ci 2.2-2.9, respectively). |
2022-09-14 |
2023-08-14 |
Not clear |
| D Florensa, J Mateo, R Spaimoc, C Miret, S Godoy, F Solsona, P Godo. Severity of COVID-19 cases in the months of predominance of the Alpha and Delta variants. Scientific reports. vol 12. issue 1. 2022-09-14. PMID:36104358. |
the risk of icu admission and death was higher in the alpha period compared to the delta as it affected the elderly and cases were less vaccinated. |
2022-09-14 |
2023-08-14 |
Not clear |
| Yongbing Zhou, Huilin Zhi, Yong Ten. The outbreak of SARS-CoV-2 Omicron lineages, immune escape and vaccine effectivity. Journal of medical virology. 2022-09-13. PMID:36097349. |
as of november 2021, several sars-cov-2 variants appeared and became dominant epidemic strains in many countries, including five vocs (alpha (1), beta (2), gamma (3), delta (4) and omicron (5) defined by the world health organization (who) during the covid-19 pandemic. |
2022-09-13 |
2023-08-14 |
Not clear |
| Natcharee Kraiwattanapirom, Vorasith Siripornpanich, Wichulada Suwannapu, Weerapon Unaharassamee, Orasa Chawang, Nalitipan Lomwong, Loukjun Vittayatavornwong, Banthit Chetsawan. The quantitative analysis of EEG during resting and cognitive states related to neurological dysfunctions and cognitive impairments in methamphetamine abusers. Neuroscience letters. 2022-09-13. PMID:36100041. |
the greater delta, alpha and beta brain waves in multiple brain areas were observed in mwp during the resting (eyes-open) state. |
2022-09-13 |
2023-08-14 |
human |
| Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, Sauhard Shrivastava, Divya Tej Sowpati, Krishnan H Harsha. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells. Microbiology spectrum. 2022-09-08. PMID:36073824. |
our biochemical and transcriptomic studies in human colon epithelial cell line caco2 reveal that alpha and delta have progressively evolved over the ancestral variants by silencing the innate immune response, thereby limiting cytokine and chemokine production. |
2022-09-08 |
2023-08-14 |
human |
| Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, Sauhard Shrivastava, Divya Tej Sowpati, Krishnan H Harsha. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells. Microbiology spectrum. 2022-09-08. PMID:36073824. |
though alpha silenced the retinoic acid-inducible gene (rig)-i-like receptor (rlr) pathway just like delta did, it failed to persistently silence the innate immune response, unlike delta. |
2022-09-08 |
2023-08-14 |
human |
| Dixit Tandel, Vishal Sah, Nitesh Kumar Singh, Poojitha Sai Potharaju, Divya Gupta, Sauhard Shrivastava, Divya Tej Sowpati, Krishnan H Harsha. SARS-CoV-2 Variant Delta Potently Suppresses Innate Immune Response and Evades Interferon-Activated Antiviral Responses in Human Colon Epithelial Cells. Microbiology spectrum. 2022-09-08. PMID:36073824. |
both alpha and delta have evolved to resist interferon (ifn) treatment, while they are still susceptible to rlr activation, further highlighting the importance of rlr-mediated, ifn-independent mechanisms in restricting sars-cov-2. |
2022-09-08 |
2023-08-14 |
human |
| Ernest R Chan, Lucas D Jones, Marlin Linger, Jeffrey D Kovach, Maria M Torres-Teran, Audric Wertz, Curtis J Donskey, Peter A Zimmerma. COVID-19 infection and transmission includes complex sequence diversity. PLoS genetics. vol 18. issue 9. 2022-09-08. PMID:36074769. |
here we present data from over 360 patients to characterize the complex sequence diversity of individual infections identified during multiple variant surges (e.g., alpha and delta). |
2022-09-08 |
2023-08-14 |
Not clear |